Responsum for CKD

{{user.displayName ? user.displayName : user.userName}}
{{ user.userType }}
Welcome to

Responsum for CKD

Already a member?

Sign in   
Do you or someone you know have CKD?

Become part of the foremost online community!

Sign Up Now

Or, download the Responsum for CKD app on your phone

Clinical and Experimental Nephrology

Clinical and Experimental Nephrology

Could Anemia Be a Sign of Renal Prognosis in ADPKD Patients?

Could Anemia Be a Sign of Renal Prognosis in ADPKD Patients?

Anemia and low hemoglobin are factors for poor kidney prognosis in autosomal dominant polycystic kidney disease (ADPKD). The effect of anemia is slightly different in men and women. These findings point to the importance of the early introduction of anemia treatment for ADPKD patients.


Published on {{articlecontent.article.datePublished | formatDate:"MM/dd/yyyy":"UTC"}}
Last reviewed on {{articlecontent.article.lastReviewedDate | formatDate:"MM/dd/yyyy":"UTC"}}

While anemia is an indicator of chronic kidney disease (CKD), it hadn’t previously been studied in autosomal dominant polycystic kidney disease (ADPKD). This is because hemoglobin (Hb) levels tend to be higher in ADPKD patients, and low Hb is typically a sign of a low red blood cell count, i.e., anemia. Thus, a recent study published in Clinical and Experimental Nephrology investigated anemia as a sign of renal prognosis in ADPKD patients.*

Background information

ADPKD is a genetic disorder caused by mutations (changes) in one of two genes: PKD1 and PKD2. Changes in these genes leads to the formation of cysts, which gradually enlarge the kidneys. Patients with this progressive disease may also have cysts in other organs, like the liver and pancreas. 

More than half of all patients with ADPKD will ultimately develop end-stage kidney disease (ESKD) and require dialysis or kidney transplantation. 

Research and investigation details

Researchers from various departments and divisions of Tokyo Women’s Medical University in Tokyo, Japan, investigated whether anemia is a possible prognostic factor in autosomal ADPKD. They examined a group of 115 non-dialysis ADPKD patients (48 men and 67 women) over a medium time of 5.5 years.

Results and conclusions

The researchers found “that anemia may be a factor for poor renal prognosis in ADPKD.” They also discovered that the effect of anemia is slightly different in men and women.

A higher risk of kidney disease progressions was seen in:

  • men with Hb levels lower than 12 g/dL (grams per deciliter), and 
  • in women with Hb levels lower than 11 g/dL.

To better understand g/dL, a gram (g) is about one-thirtieth (1/30) of an ounce, and a deciliter (dL) measures fluid volume equal to one-tenth (1/10) of a liter (L).

Therefore, anemia and low Hb are factors for poor kidney prognosis in ADPKD, which makes ADPKD similar to CKD in this regard. These findings suggest the importance of early introduction of anemia treatment for ADPKD patients

Additional information can be found in the Renal and Urology News article, “Anemia in ADPKD Possibly Linked to Poor Renal Prognosis.” 

*Ushio, Y.; Kataoka, H.; Sato, M.; Manabe, S.; et al. (2020, June). “Association Between Anemia and Renal Prognosis in Autosomal Dominant Polycystic Kidney Disease: A Retrospective Study.Clinical and Experimental Nephrology.

Source: {{articlecontent.article.sourceName}}

 

Join the CKD Community

Receive daily updated expert-reviewed article summaries. Everything you need to know from discoveries, treatments, and living tips!

Already a Responsum member?

Available for Apple iOS and Android